1 mg semaglutide weight loss Wegovy (Semaglutide) Injection (1mg) Semaglutide - Renew Body Wellness

The trial, called FLOW, started in 2019 and involved roughly 3,500 patients with Type 2 diabetes and moderate to severe chronic kidney disease, who were given 1 milligram of once-weekly semaglutide in addition to standard care

One plaintiff, Christopher Aumais, voluntarily dismissed

Both treatments produce clinically meaningful weight loss when used consistently and alongside healthy lifestyle changes

No published human trial has measured outcomes for cagrilintide + retatrutide as a stack

This means less nausea at peak, more consistent appetite suppression at trough, and a generally smoother experience throughout the week